320 related articles for article (PubMed ID: 20156748)
1. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies in Paraneoplastic Neurological Syndrome].
Kawachi I
Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
Stich O; Rasiah C; Rauer S
Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
[TBL] [Abstract][Full Text] [Related]
4. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
5. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
6. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
7. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
[TBL] [Abstract][Full Text] [Related]
11. [Neuropathy associated with paraneoplastic neurological syndrome].
Mitsui Y; Kusunoki S
Brain Nerve; 2010 Apr; 62(4):387-93. PubMed ID: 20420179
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell AR
Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
[No Abstract] [Full Text] [Related]
14. Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes.
Tampoia M; Zucano A; Antico A; Giometto B; Bonaguri C; Alessio MG; Radice A; Platzgummer S; Bizzaro N
Immunol Invest; 2010 Jan; 39(2):186-95. PubMed ID: 20136624
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
[TBL] [Abstract][Full Text] [Related]
17. Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neurons.
Tanaka K; Ding X; Tanaka M
J Neurol Sci; 2004 Jan; 217(1):25-30. PubMed ID: 14675605
[TBL] [Abstract][Full Text] [Related]
18. Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer.
Hiasa Y; Kunishige M; Mitsui T; Kondo S; Kuriwaka R; Shigekiyo S; Kanematsu T; Satake N; Bando Y; Kondo A; Endo I; Oshima Y; Matsumoto T
Clin Neurol Neurosurg; 2003 Dec; 106(1):47-9. PubMed ID: 14643918
[TBL] [Abstract][Full Text] [Related]
19. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes.
Blaes F; Klotz M; Funke D; Strittmatter M; Kraus J; Kaps M
Eur J Neurol; 2002 Jul; 9(4):369-72. PubMed ID: 12099920
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
